Cambridge, MA – January 4, 2016 – Novaseek Research announced today that the Company has been selected to deliver a corporate presentation at the first annual Digital Health Showcase, a focused program within the Biotech Showcase investor and networking conference, concurrent with JP Morgan Healthcare annual conference. The upcoming event is being held in San Francisco, CA at Parc 55. Biotech Showcase event is expected to bring together 2,100+ attendees representing the life science industry’s most enterprising and pioneering biotech companies and major players in the drug development arena.
Dr. Kate Torchilin, CEO at Novaseek Research, will be presenting on Wednesday, January 13, 2016 at 9:20 AM PT. Dr. Torchilin will provide a corporate overview of how Novaseek connects life sciences R&D with healthcare providers via proprietary IP platform, and enables broad patient participation in medical advances.
Novaseek’s first offering is transforming how researchers from industry and academia access clinical data and human biospecimens to accelerate R&D.
Novaseek connects researchers from industry and academia with healthcare providers, and enables broad patient participation in medical advances. The Novaseek Clinical Data Network for Research (CDNR) is the industry’s first comprehensive platform enabling researchers to access real-world, real-time clinical data and large quantities of high quality biospecimens – that is essential for understanding disease and developing medical advances – all in compliance with HIPAA. Incorporating Novaseek’s CDNR platform across all phases of research and development helps industry and academia generate powerful new insights, increases R&D productivity and decreases risk in the pursuit of new cures. The CDNR platform was developed by experts in drug development, hospital operations and health IT to create a win-win for industry, academia, healthcare providers and patients.